MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling

Dzieran J, Rodriguez Garcia A, Westermark UK, Henley AB, Eyre Sánchez E, Träger C, Johansson HJ, Lehtiö J, Arsenian-Henriksson M

Proc Natl Acad Sci USA 115 (6) E1229-E1238 [2018-02-06; online 2018-01-26]

Chemical Proteomics & Proteogenomics [Collaborative]

QC bibliography QC xrefs

DOI 10.1073/pnas.1710901115

Crossref 10.1073/pnas.1710901115